TRIB1 and non-small cell lung carcinoma: A later report showed that downregulation of p53 by the TRIB1-HDAC1 interaction induces resistance to cisplatin chemotherapy and cancer stem cell enrichment in non-small cell lung carcinoma (NSCLC) [93].